Drug Type Small molecule drug |
Synonyms- |
Target |
Action positive allosteric modulator |
Mechanism mGluR2 positive allosteric modulator(Metabotropic glutamate receptor 2 positive allosteric modulator), mGluR3 positive allosteric modulator(Metabotropic glutamate receptor 3 positive allosteric modulator) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H22ClNO5 |
InChIKeySRGMPUVJRINMDU-UHFFFAOYSA-N |
CAS Registry3067362-81-3 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Central Nervous System Diseases | Preclinical | United States | 18 Jun 2025 |





